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ABSTRACT 
 Recently, it has been discovered that null mutations in progranulin is a cause of familial 
frontotemporal dementia. To understand the role of progranulin in this neurodegenerative 
disorder, transgenic null mice and in vitro knockdown of mRNA for progranulin were analyzed. 
After verifying the transgenic mice using Polymerase Chain Reaction to verify progranulin 
knockdown, the HomeCageScan System and the rotarod test were performed to investigate 
motor neuron function. In vitro progranulin knockdown in NSC-34 cells was confirmed using 
RNA extraction and northern blots. The cells that exhibited at least 50% knockdown will be 
further analyzed in the morphological changes associated with the progranulin 
haploinsufficiency. 
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BACKGROUND 
Familial Frontotemporal Dementia 
Definition 
Frontotemporal dementia (FTD) is a disorder that involves the neurodegeneration of the 
frontal and temporal lobes (Rosso, et al., 2001). The typical onset of FTD ranges from 40 to 64 
years of age, with an average duration of between two to ten years (Mayo Clinic Staff, 2007). It 
is the second most common cause of presenile dementia, following Alzheimers disease. FTD 
accounts for up to 20% of all dementia beginning before the age of 65 years. (Snowden, Neary, 
& Mann, 2002).  
Symptoms 
 The signs and symptoms of FTD vary from person to person, however the most common 
abnormalities can be categorized as behavioral changes, speech and language comprehension, 
and movement disorders. Unlike Alzheimers disease, memory problems are not associated with 
FTD in the early stages (Mayo Clinic Staff, 2007). 
The most common presentation is changes in behavior and personality.  These are 
extreme changes which include lack of judgment and inhibition, decline in personal hygiene, 
apathy, increasingly inappropriate actions, and repetitive compulsive behavior (Mayo Clinic 
Staff, 2007). 
 Changes in language function are a less common symptom of FTD. Difficulties that may 
develop consist of problems in the expression of language, reading, and writing. As the disease 
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progresses, mutism may ensue and language is used less and less (The Regents of the University 
of California, 2008).   
 Movement disorders similar to Parkinsons disease can occur in a subtype of FTD called 
corticobasal degeneration. The signs and symptoms include poor coordination, rigidity, impaired 
balance, tremor, and muscle spasms. A loss in the ability to carry out purposeful movements can 
also occur. Frontotemporal dementia with motor neuron disease (FTD/MND) is when movement 
problems occur along with symptoms of amyotrophic lateral sclerosis. Weakness, muscle 
shrinkage, muscle spasms, and difficulty swallowing are common signs (Mayo Clinic Staff, 
2007). 
Causes 
 FTD has a strong genetic component. The disorder is 35-50% familial with autosomal 
dominant inheritance. In 1998, the first mutation that was identified as being linked to FTD was 
found on chromosome 17 for microtubule-associated protein tau (MAPT) (Mackenzie, et al., 
2006). Since then, over thirty nine different MAPT mutations have been discovered. These 
mutations are characterized by tau-positive inclusions and account for 10-20% of familial FTD 
(Eriksen & Mackenzie, 2008).  
 However, there have been cases of familial FTD with linkage to the same chromosome 
17q21 but lack MAPT mutations (Baker et al., 2006; Eriksen & Mackenzie, 2008). These cases 
demonstrated tau-negative, ubiquitin-positive inclusions (Goedert & Spillantini, 2006), which 
represents highly-regulated protein degradation through the ubiquitin protease pathway (Boston 
Biochem, Inc., 2005). Recent discoveries have identified the cause of these tau-negative FTD 
cases as mutations in the progranulin gene on chromosome 17q21. With 5-10% of FTD patients 
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having mutations in the progranulin gene, it is as common as MAPT mutations (Eriksen & 
Mackenzie, 2008). Figure 1 below shows the location of the progranulin and MAPT gene on 
chromosome 17q21.  
 
Figure 1: Chromosome 17 with MAPT and progranulin locations marked. Mutations in both these regions on 
chromosome 17q21 cause FTD. The schematic representation provided by (Baker, et al., 2006). 
 
Progranulin  
Location and Function 
 Progranulin is glycoprotein consisting of 593 amino acids whose gene is found on 
chromosome 17q21.32. It is present in a variety of tissues throughout the body, including in 
epithelial and hematopoietic cells (Eriksen & Mackenzie, 2008). Progranulin is multifunctional 
secreted growth factor involved in cell cycle progression and cell motility. The function of 
progranulin also includes development, wound repair, and inflammation (Mackenzie, et al., 
2006).  
In the central nervous system, the role of progranulin is unsure, however, it is extensively 
expressed during early stages of neural development. Later, progranulin is only expressed in 
certain neuronal populations such as cortical and hippocampal pyramidal neurons and purkinje 
cells. In activated microglial cells, progranulin expression is up-regulated (Van Damme, et al., 
2008). 
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Role in FTD 
 Previous studies have shown FTD is a result of mutations of the progranulin gene, 
including frameshift, splice-site, nonsense, signal peptide, Kozak sequence disruption, and 
missense mutations. The majority of these mutations result in premature termination codons 
which leads to the degradation of the mutant mRNA by nonsense mediated decay. The outcome 
is a functional null allele, or non-functional or unstable proteins in the case of a missense 
mutation (Eriksen & Mackenzie, 2008). 
 Unlike tauopathies, which share the pathological feature of accumulation of insoluble 
hyperphosphorylated tau proteins, the mutant progranulin is absent in the cells of the nervous 
system of FTD patients. Instead, the disorder is a result of a loss of functional progranulin. The 
progranulin gene consists of several different regions, and through past studies, it was concluded 
that mutations in the various regions result in FTD through the common mechanism of 
haploinsufficiency (Mackenzie, et al., 2006). 
 The effects of the deficiency of functional progranulin can be studied through a 
knockdown approach. RNA interference can be used to mimic the disease in order to observe 
and analyze the impact of this missing protein. 
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RNA Interference 
Application 
 RNA interference (RNAi) is tool used in a variety of applications to down-regulate the 
expression of certain genes for basic studies of gene function or translational research. The uses 
of RNAi in translational research include producing models for human diseases, exploring the 
possible side effects of prospective drugs, and testing potential gene therapies (Wiznerowicz, 
Szulc, & Trono, 2006). 
RNAi Systems 
 The desirable product of RNAi is knockdown that can be externally controlled. There are 
two systems that result in different types of knockdown.  Inducible knockdown usually involves 
the use of chemicals and is used to research the function of genes that are necessary for 
development into differentiated tissues in transgenic models. Conditional knockdown is 
commonly used to produce human pathologies in vivo, which allows for the elimination of 
disease-influencing genes to be induced and reverted at will. This type of knockdown can be 
either reversible or nonreversible (Wiznerowicz, Szulc, & Trono, 2006).  
 Reversible conditional systems involve pharmacologically managed expression of 
specific interfering RNAs. For the research on progranulin, micro-RNA (miRNA) was used as 
the interfering RNA for in vitro experiments. When doxycycline is added, the miRNA is 
induced, which complements the target RNA in order to prevent the translation of a specific 
protein. Doxycycline-controlled units are commonly used since it is easy to add to cell cultures 
or distribute to animals (Wiznerowicz, Szulc, & Trono, 2006).  
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Figure 2 shows the design and mode of action of a reversible system through the 
mechanism of steric hindrance. This model uses doxycycline as the inducer. In the absence of the 
inducer, the interfering RNA, in this case the silencing RNA (siRNA), is not expressed. This is 
because the tetracycline repressor (tetR) is blocking the promoter. As soon as doxycycline is 
added to the system, the tetR is sequestered, and the transcription of the siRNA is induced. 
 
Figure 2: Reversible conditional system involving steric hindrance-mediated repression before and after doxycycline is 
added; provided by (Wiznerowicz, Szulc, & Trono, 2006). 
 
 Irreversible conditional systems produce permanent knockdown. It involves 
recombinases such as Cre or Flp to excise an inactivating sequence which then induces the 
expression of the interfering RNA. This is a one-time event that cannot be switched back into the 
original state. The irreversible systems are generally used to create conditional-knockdown 
animals or models (Wiznerowicz, Szulc, & Trono, 2006). 
 Figure 3 illustrates the design of the Cre-inducible miRNA complex. Without the 
addition of Cre, the Enhanced Green Fluorescent Protein (EGFP) is expressed under green 
fluorescent light. Once Cre is added, the fragment between the loxP is cut out, allowing the Red 
Fluorescent Protein (RFP) and miRNA to be expressed. 
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Figure 3: Irreversible conditional system involving the expression of the miRNA after the addition of Cre; provided by 
(Xu, 2008) 
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PROJECT PURPOSE 
 In order to analyze the effect of the loss of progranulin, an induced silencer needed to be 
transfected in vitro. NSC-34 neural cells were used to observe the function of progranulin in 
neurite growth, survival, and apoptosis. The first action needed was to induce knockdown. The 
hypothesis was that by producing a stable transfected cell line, 50% knockdown of mRNA for 
progranulin could be acquired. This was tested through RNA extraction and northern blots. Once 
stable cell lines with at least 50% knockdown were confirmed, the effect of progranulin could be 
observed. 
 In addition, the phenotype of a haploinsufficiency of progranulin was developed through 
the analysis of transgenic mice. Polymerase Chain Reaction was used to identify the mice 
expressing the miRNA that knocks down progranulin. The HomeCageScan System and the 
rotarod systems were used to examine the motor coordination and behavioral function of the 
transgenic mice. The hypothesis was that the mice with the knockdown of progranulin would not 
exhibit as high of motor function as the wild mice. For the HomeCageScan System, it was 
predicted that the transgenic mice would not travel as far as the wild mice and would spend a 
higher fraction of time resting as opposed to energetic behaviors. For the rotarod test, it was 
predicted that the transgenic mice would not be able to remain on the rod for as long as the wild 
mice. The loss of progranulin would decrease the motor coordination and function.    
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MATERIALS AND METHODS 
 
Transgenic Animal Model 
Polymerase Chain Reaction (PCR) 
  To verify the presence of the transfected DNA construct in the transgenic mice, two 
process were completed. First, the tail sample of each mouse was observed under green 
fluorescent light. If the transgene was incorporated into the mouse genome and was active, then 
the sample tail would appear to be fluorescent green due to the expression of the EGFP marker in 
the construct.   
In order to confirm the existence of the miRNA, the polymerase chain reaction (PCR) 
was performed. This procedure amplified the DNA construct containing the EGFP and miRNA 
genes if it was present in the mouse sample. The first step was to digest the mice tail samples by 
rotating the tubes in lysis reagent overnight as according to the DirectPCR Lysis Reagent (Tail) 
procedure provided by Viagen Biotech, Inc (Viagen Biotech, Inc., 2007). 
Once the tails were digested, the PCR reagent was mixed by combining the necessary 
components with the appropriate concentration according to Table 1. Twenty micro liters of the 
PCR reagent was added to each labeled tube of one micro liter of DNA sample. The samples 
were then put in the Peltier Thermal Cycle set to a program that consisted of 94ûC for 2 minutes, 
33 cycles of 94ûC for 30 seconds, 64ûC for 30 seconds, and 72ûC for 30 seconds, followed by 
72ûC for 5 minutes, and 4ûC until needed. 
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Table 1: Component and Concentrations for PCR reagent mix 
 
While the thermal system was finishing, an agarose gel was made. The samples were then 
placed in the electrophoresis gel consisting of 2% agarose in 1X TAE and ~5 µl of Ethidium 
Bromide. The electrophoresis was then run at 100V for ~20 minutes. Photos of the samples in 
the gel were taken using ultraviolet light. Dark bands represented the presence of the target DNA 
in the cells. 
Rotarod 
 The rotarod is a treadmill-like machine that analyzes the motor coordination and fatigue 
of the mice. It consists of a rotating rod that gradually increases in rpm until the mice all fall off. 
The bottom of the machine is touch-sensitive, so once the mice hit the bottom, the timer stops. 
The recorded time that the mice were able to remain on the rotating rod is related to the motor 
functions.  
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HomeCageScan System 
 The HomeCageScan System is a video-based approach that recognizes behavior. Two 
mice at a time were placed in separate cages with fixed cameras for a period of around four 
hours. The cameras were connected to the HomeCageScan System program on the computer, 
where the movements and behavior of the two mice were categorized (Steele, Jackson, King, & 
Lindquist, 2007).  
At the end of the session, a detailed analysis of the seconds and fraction of time spent for 
each behavior group was exported onto an excel sheet. The data for each set of mice was then 
further examined through graphs and statistical analysis. The behaviors of the double construct 
and wild type mice were compared. 
 
In vitro Progranulin Knockdown 
Antibiotic Sensitivity  
 The cells that were cultured for the in vitro progranulin knockdown were NSC-34 cells, 
which is a motor neuron-like hybrid cell line. It is a hybrid line composed of motor neuron 
embryonic spinal cord cells and mouse neuroblastoma, which are cancer cells (CELLutions 
Biosystems, Inc., 2006).  
 The first step in developing the stable cell line was to culture the NSC-34 cells and 
determine the antibiotic sensitivity. It is necessary to know the minimum concentration of G418 
that will kill the nontransfected cells, leaving the transfected cells containing the resistant gene 
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remaining. The procedure for determining the antibiotic sensitivity was followed according to 
the protocol of Transfection with pTK-neo (Novagen, 2003). 
 A necessary component to determine the antibiotic sensitivity was to observe the 
percentage of survival of the cells. The method to establish the number of viable cells in the 
cytotoxicity assay was followed according to the CellTiter 96 AQueous One Solution Cell 
Proliferation Assay protocol (Promega, 2007). 
Transfection  
 Once the antibiotic sensitivity was determined, the cells were transfected with a net 
solution containing the target DNA construct, Lipofectamine 2000, and pTK-neo plasmid 
according to Lipofectamine 2000 Plasmid DNA Transfection. The lipofectamine 2000 is lipid-
based and allows the passage of the target DNA through the cell plasma membrane by binding to 
the DNA (Invitrogen, 2006). The pTK-neo plasmid allows the transfected cells to be resistant to 
G418 through the neomycin resistant gene (Novagen, 2003). 
Stable Cell Line  
 When the cells were transfected with the target DNA, only some of the cells incorporated 
the DNA into their genome. For accurate results, it is necessary to develop a stable cell line, with 
100% transfected NSC-34 cells. This was done in concurrence to the procedure of Transfection 
with pTK-neo (Novagen, 2003). 
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RNA Extraction 
 To verify the stable cell line, two methods were used. First, the cells were observed under 
a green fluorescent light. If the cells had incorporated the target DNA, then these cells would 
glow bright green. This is the result of the EGFP fragment of the target DNA construct. 
 Secondly, the miRNA, which knockdown the progranulin protein, is verified through the 
northern blot. An essential step before the northern blot is RNA extraction. Once cells have been 
cultured to a certain concentration, the RNA was isolated according to the RNA STAT-60 
Procedure (Tel-Test). A small sample of the isolated RNA was used to determine the optical 
density, or the concentration of RNA per sample, so that equal loading could be used in the 
northern blot.  
Northern Blot 
 With the RNA isolated from the sample cells, a northern blot was performed in order to 
detect the presence of mRNA for progranulin. Supposedly, the noninduced cells would be 
positive and the induced cells would be negative, because of the expressed knockdown of 
progranulin.  
 The gel was prepared by adding ambion agarose-LE to DEPC-treated distilled water. The 
NorthernMax 10X Denaturing Gel Buffer was added and allowed to solidify. In the meantime, 
the RNA samples were prepared by adding RNA samples, DEPC-treated distilled water, and 
formaldehyde load dye. It was denatured and then electrophoresed at 70V for 1.5 hours. The gel 
was photographed in order to confirm equal loading and then transferred to a BM nylon 
membrane.  
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 The RNA was fixed on the membrane by UV crosslinking. This way, there was no loss of 
RNA. In order to view only the mRNA for progranulin, dig-labeled RNA probes were 
synthesized with SP6/T7 Transcription Kit (Roche). The membrane was then hybridized with the 
probe at 50ûC overnight, followed by two washes at 50ûC for 15 minutes. The northern blot 
images were developed with the LAS-3000 imaging system and quantified by the Multi-Guage 
software (FujiFilm).    
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RESULTS 
 In order to analyze the effect of the knockdown of progranulin in mice, the knockdown 
must first be verified. This was done through Polymerase Chain Reaction. Figure 4 shows the 
results of eight mice with the ladder on the left. The dark bands represent the positive transgenic 
mice that exhibit the miRNA and therefore express the RNA to knockdown progranulin mRNA. 
 
Figure 4: PCR of tail samples 
 After confirming the double construct mice from the wild type mice, behavioral tests 
were performed so that a phenotype could be established. The HomeCageScan System was used 
to analyze the behavior of the mice over a period of ~4 hours during the afternoon. For each 
session, a wild type mouse and a double mouse was put into the system. The averages for the 
wild type and double mice were calculated for the number of seconds and the fraction of time 
spent during each behavioral group. The results are displayed in Table 2. 
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Table 2: Results of the HomeCageScan System 
 
 Another vital component to the HomeCageScan System is that it records the distances 
traveled for each mouse in meters. This is beneficial for the analysis of the loss of functional 
progranulin because it could represent fatigue and low engery. The distance traveled for each 
mouse and the averages for the double and wild mice are presented in Table 3. 
Table 3: Comparison of the distance traveled in meters for wild type mice and double mice in the HomeCageScan System 
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 A column graph was developed in order to visualize the differences in the fraction of 
time spent performing each behavior. The wild type and double mice were compared and 
analyzed for correlations with the loss of the progranulin function. Figure 5 illustrates the 
comparison of the two mice groups. As shown, the double construct mice spent a greater fraction 
of time resting as opposed to the wild type mice. 
 
Figure 5: Graph of the percentage of time the double mice and wild type spent for each behavior group in the 
HomeCageScan System 
 The rotarod test was used to further analyze the motor function of the mice. The results of 
the wild type  and double mice were compared for different age groups. The rotarod test was 
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performed at 2, 4, 6, 8, and 10 months of age for the mice and the averages of the results for each 
age group were calculated. Table 4 displays the average time for each group of mice. 
Table 4: Results of the rotarod test (Average time in seconds) 
 
The data from the rotarod test was then analyzed further. A line graph was used to demonstrate 
the differences in the time remaining on the the rotarod for the double and wild mice in Figure 6. 
The results reveal that, on average, the wild type mice remained on the rotarod for longer amount 
of time than the double construct mice.   
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Figure 6: Graph of results from rotarod test illustrating the average time for the different ages 
 The first method that was used to confirm the incorporation of the target DNA construct 
into the cells was green fluorescent light. The cells were placed under a microscope at 20X 
magnification with green fluorescent light. If the cells contained the target DNA in their genome, 
then they would fluoresce green. Figure 7a displays a positively transfected stable cell line. 
Figure 7b shows the same cells under normal light, and Figure 7c is a photo combining the cells 
under green fluorescent light and the cells under normal light. This allows for any cells that are 
not expressing the EGFP to be visible. Figure 7c shows that all the cells are green, which means 
that this cell line was 100% stable. 
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(a)                                           (b)             (c) 
Figure 7: Transfected cell line magnified at 20X showing (a) expression of Enhanced Green Fluorescent Protein (EGFP) 
under green fluorescent light, (b) same cells under normal light, and (c) combined photo in order confirm 100% 
transfection. 
 The second method that was performed was the northern blot to validate the presence of 
the miRNA. For accuracy, equal loading was necessary. Figure 8 displays the eight cell samples 
that were used. As seen in the photo, the darkness of the ribosomal RNA bands is equal, meaning 
equal loading was used in the northern blot. 
 
 
Figure 8: Equal loading for northern blot 
 The next step was to transfer the RNA downward to the BM nylon membrane and use 
premade dig-probes to target the mRNA for progranulin. The images were produced using the 
LAS-3000 imaging system. Figure 9 displays the results of the northern blot of the eight cell 
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samples. As shown, samples 1, 3, 5, and 7 represent brighter bands, which means that these cells 
have a higher quantity of mRNA for progranulin.   
1 2 3 4 5 6 7 8
Line R3 Samples
 
Figure 9: Results of nothern blot for R3 cell lines under 8 minutes of exposure 
 The samples are defined in Table 4. The samples with the brighter bands were in fact 
cells that were not induced, meaning they should have contained a higher number of mRNA for 
progranulin. The data was quantified using the Multi-Guage software (FujiFilm). The intensity of 
the bands was used to calculate the knockdown efficiency of the cell lines. The results are 
summarized in Table 5.  
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Table 5: Knockdown Percentage at mRNA Level for noninduced VS induced cells 
Sample Intensity(Area Under - Background)
Knockdown 
Efficiency
(1-2)/1
1 R341-5 Control 15,433,469
2 R341-5 Induced 2,730,464
3 R356-5 Control 15,198,504
4 R356-5 Induced 9,242,124
5 R345-10 Control 17,686,258
6 R345-10 Induced 4,726,653
7 R345-4 Control 14,815,493
8 R345-4 Induced 967,840
B 0
B 528,401
82.31%
39.19%
73.27%
93.47%
R3 Line
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DISCUSSION 
 This project consisted of two separate methods of analyzing the role of progranulin in 
FTD. Transgenic mice were used to develop an appropriate phenotype for the haploinsufficiency 
of progranulin. By comparing the behavior and motor functions of the transgenic (double) mice 
with the wild mice, the data could be used to examine the exact effect of the loss of progranulin 
and how its function in FTD.  
 The data generated from the HomeCageScan System supported the hypotheses that the 
transgenic mice would spend a higher fraction of time resting and the distance traveled in meters 
would be lower. On average, the transgenic double mice traveled 53.96 meters whereas the wild 
mice traveled 119.33 meters. The transgenic mice also spent the majority, 68.91%, of the time 
resting. The wild mice rested 49.8%, however, they were very active compared to the transgenic 
mice. The wild mice spent a greater fraction of time with cage top activity, exploratory, feeding, 
locomotion, and rearing.  
 From the rotarod test, it was concluded that the transgenic double mice were not able to 
remain on the rod as long as the wild mice. From ages two months to ten months, the average 
time in seconds that transgenic mice generated ranged from 3.67 seconds to 27.11 seconds. The 
wild mice ranged from 58.36 seconds to 126.08 seconds from ages two to ten months. As 
predicted, the loss of progranulin severely effected the motor function as observed by the rotarod 
test. 
 The second method used to examine the role of progranulin in FTD was inducing 
knockdown in vitro. Through RNA extraction and northern blots, the knockdown of the stable 
transfected cell lines was verified. A successful cell line was defined to have at least 50% 
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knockdown of mRNA for progranulin. The cell lines that did not reach this expectation were 
discarded, and only those cell lines with at least 50% knockdown would be used for further 
morphological analysis. The positive cell lines that met the knockdown expectation ranged from 
73.37% to 93.47% knockdown of mRNA for progranulin.  
  The data that was generated through the analysis of the transgenic mice and in vitro 
knockdown is supported by other journal articles previously published. The Neuropathology of 
Frontotemporal Lobar Degeneration Caused by Mutations in the Progranulin Gene by 
Mackenzie, et al. concludes that an important cause of familial FTD is the null mutation of 
progranulin. Their studies explain how the there is linkage to chromosome 17q21 in families 
with FTD without identifiable MAPT mutations (Mackenzie, et al., 2006). 
 As shown by the data from the behavioral tests, the loss of progranulin severely affects 
the motor neuron function of the mice. This is supported by the journal article Progranulin 
Functions as a Neurotrophic Factor to Regulate Neurite Outgrowth and Enhance Neuronal 
Survival by Van Damme, et al., which examined the function of progranulin. The experiments 
performed by Van Damme, et al. revealed that progranulin is a neurotrophic factor that has a 
positive influence on neuronal survival and axonal outgrowth. The authors from the article 
concluded that the lack of progranulin through mutations leads to neurodegeneration (Van 
Damme, et al., 2008). 
 As suggested by Eriksen and Mackenzie in Progranulin: Normal Function and Role in 
Neurodegeneration, further research is needed to understand the exact mechanism by which the 
loss of functional progranulin leads to neurodegeneration as seen in patients with FTD. More 
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knowledge is needed of the trophic properties of progranulin in order to determine the role of 
progranulin mutations in these disorders (Eriksen & Mackenzie, 2008).  
 Future experiments involving the transgenic mice include a more detailed analysis of the 
behavior at varying ages. The results from the HomeCageScan System did not take into 
consideration the age or sex of the mice. As for the rotarod test, the mice used in this experiment 
will need to be further observed as they continue to age. The data from the rotarod test will be 
used to understand the long-term affect of progranulin on the motor neuron coordination of the 
mice. 
 Having verified a stable transfection with at least 50% knockdown of mRNA for 
progranulin in vitro, future research involves observing the morphological changes. The cells 
will be cultured in special medium, allowing them to differentiate. The induced cells will then be 
compared to the non-induced cells in order to understand the function of progranulin. The three 
factors to be examined as the cells differentiate would be survival, neurite growth, and apoptosis.  
 Depending on the results, further research could include knockdown in primary neuron 
cells as opposed to the NSC-34 cells. This experiment would represent the true effect of the loss 
of progranulin in cells in the human body.  
 The recent discovery of progranulin mutations as a cause of FTD has explained the 
linkage of chromosome 17q21 without the MAPT mutations. The results of this project involving 
the transgenic mice as well as the in vitro knockdown support this discovery. Although the exact 
mechanism of the haploinsufficiency of progranulin is still unknown, this project as well as 
previously published ones is narrowing down on the role of progranulin mutations in FTD. The 
phenotype and morphological changes are becoming understood, and with further research, 
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therapeutic interventions for familial FTD with progranulin haploinsufficiency will progress 
(Eriksen & Mackenzie, 2008). 
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